| Application no. and date | 15157348.2 (espacenet) (Federated) (European Patent Register), 20110328 | | Patent/reg. no. and date | DK/EP 2924034, 20161102 | | Publication date | 20150930 | | Priority no. and date | US 318824 P, 20100330, US 321573 P, 20100407 | | EP pub. no. and date |
EP 2924034 20150930 | | Effective date | | | Applicant/owner | Merck Canada Inc., 16711 Trans-Canada Highway
Kirland QC H9H 3L1, CA | | Applicant ref. no. | V138850DK | | Inventor | Burch, Jason, 2645 Brewster Avenue
Redwood City, CA California 94062, US,
Cote, Bernard, 113 Lucien Theriault
Notre-Dame-de-l'll-Perrot, Québec J7V 7P2, CA | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 31/18 (2006.01) , C07D 401/06 (2006.01) | | Title | FARMACEUTISK SAMMENSÆTNING, DER OMFATTER EN IKKE-NUKLEOSID REVERSE
TRANSKRIPTASEINHIBITOR | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2019 00024 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
